An Industry perspective on the FDA biomarker qualification effort

Mark E Arnold
  • Bioanalysis, June 2018, Future Science
  • DOI: 10.4155/bio-2018-0049
The author haven't yet claimed this publicationThe author haven't yet claimed this publication

In partnership with: